Key facts
- This page summarizes Robin Kramer's Form 4 filing for BIOGEN INC. (BIIB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jul 2023, 17:35.
Robin Kramer - 30 Jun 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- Chief Accounting Officer
- Issuer ticker
- BIIB
- Reported as of
- 30 Jun 2023
- Net transaction value
- -$34,752
- SEC form
- 4
- Accepted by SEC
- 05 Jul 2023, 17:35:35 UTC
- Prior SEC filing
- 22 Feb 2023
- Next SEC filing
- 12 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wendell Taylor, attorney-in-fact for Robin Kramer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robin Kramer filed Form 4 for BIOGEN INC. (BIIB) on 05 Jul 2023.
Change
- Previous filing in this sequence was filed on 22 Feb 2023.
- Current net transaction value: -$34,752.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +252
- Change %
- +6.6%
- Price
- $0.000000
- Shares after
- 4,096
- Date
- 30 Jun 2023
- Ownership
- Direct
BIIB
transaction
Common Stock
Tax liability
- Transaction value
- $34,752
- Shares
- -122
- Change %
- -3%
- Price
- $284.85
- Shares after
- 3,974
- Date
- 30 Jun 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIIB
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -252
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 30 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 252
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The restricted stock units vested in three (3) equal annual installments commencing one year after the grant date of 07/01/2020.